Background illustration for clinical trials search

Myasthenia Gravis Clinical Trials

Browse 56 myasthenia gravis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

for
Myasthenia Gravis,
Location: Morgantown WV
Sponsor: argenx

Sex: Female

Age: 0+

Code: NCT06299748

Recruiting

Physical Activity Monitoring in Myasthenia Gravis

for
Myasthenia Gravis
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT06277830

Recruiting

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

for
Childhood-onset Systemic Lupus Erythematous,
Location: Washington D.C. DC, Cincinnati OH, St Louis MO
Sponsor: Cartesian Therapeutics

Sex: All

Age: 12+

Code: NCT07089121

Phase1, Phase2, Recruiting

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

for
Myasthenia Gravis
Location: Philadelphia PA, Hershey PA, Tampa FL, Ann Arbor MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 2 - 17

Code: NCT05265273

Phase2, Phase3, Recruiting

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis, gMG
Location: Norfolk VA, Washington D.C. DC
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 6 - 17

Code: NCT06607627

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

for
Generalized Myasthenia Gravis
Location: Foxborough MA, The Bronx NY, New York NY,
Sponsor: Vor Biopharma

Sex: All

Age: 18+

Code: NCT06456580

Phase3, Recruiting

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

for
AChR-Ab Seropositive Generalized Myasthenia Gravis,
Location: Miami FL, Amherst NY, Chattanooga TN
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07673627

Phase2, Recruiting

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

for
Myasthenia Gravis, Generalized
Location: Boca Raton FL, Miami FL, Homestead FL,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07596901

Phase1, Phase2, Recruiting

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

for
Generalized Myasthenia Gravis, gMG
Location: Raleigh NC
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07221838

Recruiting

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

for
Myasthenia Gravis
Location: New Haven CT, Ottawa, Durham NC, Boca Raton FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT04951622

Phase3, Recruiting

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

for
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis,
Location: Columbia MO
Sponsor: University of Missouri-Columbia

Sex: All

Age: 18+

Code: NCT07478172

Recruiting

Zilucoplan for Severe gMG Exacerbations

for
Generalized Myasthenia Gravis (gMG)
Location: Columbus OH
Sponsor: Miriam Freimer

Sex: All

Age: 18+

Code: NCT07215949

Phase3, Recruiting

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

for
Myasthenia Gravis, MG, gMG, Generalized Myasthenia Gravis,
Location: Boston MA, Durham NC, Miami FL, Amherst NY, Tampa FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07294170

Recruiting

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

for
AChR-Ab Seropositive Generalized Myasthenia Gravis,
Location: Boston MA, Durham NC, Miami FL, Amherst NY, Tampa FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07284420

Phase2, Recruiting

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

for
Myasthenia Gravis
Location: Farmington CT, New York NY, Raleigh NC, Boca Raton FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07217587

Phase3, Recruiting

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

for
Generalized Myasthenia Gravis
Location: Philadelphia PA, Austin TX
Sponsor: Amgen

Sex: All

Age: 2 - 17

Code: NCT06987539

Phase2, Recruiting

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis (gMG)
Location: Boston MA, Worcester MA, New York NY, Rochester NY,
Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 70

Code: NCT06359041

Phase1, Phase2, Recruiting

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

for
Myasthenia Gravis, Generalized
Location: Boca Raton FL, Houston TX
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07647510

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

for
Myasthenia Gravis
Location: New Bern NC, Clearwater FL, Farmington Hills MI,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07673744

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

for
Ocular Myasthenia Gravis
Location: Montreal, Amherst NY, Columbus OH, Greenfield WI,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 18+

Code: NCT07463521

Phase3, Recruiting